Keywords
How to Cite
Abstract
This work presents results of the analysis of safety and efficacy of laparoscopic superextended lymphadenectomy, which was performed in patients with clinical progression (the presence of lesions in the lymph nodes of the pelvis and beyond) after undergoing prostatectomy. A feature of the work is that these patients initially extended lymphadenectomy was performed. Clinical detection of foci was carried out by 11C-PET/ CT. Laparoscopic salvage lymphadenectomy appears to be the safe method of performing surgery. When monitoring patients there was evaluated the effectiveness of the operation - the percentage of patients with marked regression and stabilization of markers (PSA), duration of remission. The analysis of the data attempted to determine the predictors of non-response patients after salvage lymphadenectomy.References
Алексеев Б.Я., Нюшко К.М., Воробьев Н.В. и др. Частота и локализация метастазов в лимфатических узлах при выполнении радикальной простатэктомии и расширенной тазовой лимфаденэктомии у больных раком предстательной железы // Онкоурология. - 2012. - № 1. - С. 77-81.
Abdollah F., Briganti A., Montorsi F. et al. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy // Eur Urol. - 2015. - Vol. 67 (5). - P. 839-849.
Abdollah F, Karnes RJ, Suardi N. et al. Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer // J Clin Oncol. - 2014. - Vol. 32 (35). - P. 3939-3947.
Bader P, Burkhard FC, Markwalder R. et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? // J Urol. - 2002. - Vol. 168 (2). - P. 514-518.
Birkhuser FD, Studer UE, Froehlich JM. Et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normalsized pelvic LNs of patients with bladder and prostate cancer // Eur Urol. - 2013. - Vol. 64. - p. 953-960.
Choyke ML. Advanced imaging for recurrent prostate cancer: is future now? // Urology Times. - 2015. - Vol. 11. - P. 4.
Curcio L, Cunha AC, Renteria J, Presto D. Laparoscopic resection of tumor recurrence after radical nephrectomy for localized renal cell carcinoma // Int Braz J Urol. - 2014. - Vol. 40 (3). - P. 431.
Dell’Oglio P, Karnes RJ, Joniau S. et al. Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer // Urol Oncol. - 2016. - in press.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey // Ann Surg 2005. - Vol. 240. - P. 205-213.
Engel J, Bastian PJ, Baur H. et al. Survival benefit of radical prostatectomy in lymph node positive patients // Eur Urol. - 2010. - Vol. 57. - P. 754-761.
Faiena I, Singer E, Pumill C, Kim I. Cytoreductive prostatectomy: evidence of support a new surgical paradigm (Review) // Int J Oncol. - 2014. - Vol. 45. - P. 2193-2198.
Gandaglia G, Karakievicz PI, Briganti A. et al. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer // Eur Urol. - 2015. - Vol. 68 (2). - P. 325-334.
Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis // J Urol. - 2002. - Vol. 167 (4). - P. 1681-1686.
Hong MKH, Macintyre G, Wedge DC. et al. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer // Nat Commun. - 2015. - Vol. 6. - P. 1-12.
Kim DS, Jeon SH, Chang SG, Lee SH. Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy // Korean J Urol. - 2015. - 56. - Vol.10. - P. 703-709.
Mattei A, Fuechsel FG, Bhatta Dhar N. et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study // Eur Urol. - 2008. - Vol. 53. - P. 118-125.
Meijer HJ, Debats OA, Kunze-Busch M. et al. Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer // Int J Radiat Oncol Biol Phys, 2012. - Vol. 82. - P. 175-183.
Mohler JL. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer // J Natl Compr Canc Netw. - 2010. - Vol. 8. - P. 145.
Mohler JL, Armstrong AJ, Bahnson RR. et al. Prostate Cancer, Version 1.2016 // J Natl Compr Canc Netw. -2016. - Vol. 14 (1). - P. 19-30.
Nini A, Gandaglia G, Fossati N. et al. Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival // Eur Urol. - 2015. - Vol. 68 (5). - P. 777-784.
Osmonov DK, Heimann D, Janen I. et al. Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence // Springerplus. - 2014. - Vol. 3. - P. 340.
Pond GR, Sonpavde G, de Wit R. et al. The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer // Eur Urol. - 2014. - Vol. 65 (1). - P 3-6.
Reeves F, Costello A. Is there a place for cytoreduction in metastatic prostate cancer? // BJU Int. - in press.
Renehan AG. Techniques and Outcome of Surgery for Locally Advanced and Local Recurrent Rectal Cancer // Clin Oncol (R Coll Radiol). - 2016. - Vol. 28 (2). - P. 103-115.
Rigatti P, Suardi N, Briganti A. et al. Pelvic/ retroperitoneal salvage LN dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography // Eur Urol. - 2011. - Vol. 60. - P. 935-943.
Santeufemia DA, Lumachi F, Basso SM. et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy as salvage treatment for a late wound recurrence of endometrial cancer // Anticancer Res. - 2013. - Vol. 33 (3). - P. 1041-1044.
Scattoni V, Picchio M, Suardi N. et al. Detection of LN metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: Results confirmed by open pelvic retroperitoneal lymphadenectomy // Eur Urol. - 2007. -Vol. 52. - P. 423-429.
Schumacher MC, Burkhard FC, Thalmann GN. et al. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy // Eur Urol. - 2008. - Vol. 54 (2). - P. 344-352.
Sugarbaker PH. Improving oncologic outcomes for colorectal cancer at high risk for local-regional recurrence with novel surgical techniques // Expert Rev Gastroenterol Hepatol. - 2015. - Vol. 7. - P. 1-9.
Supiot S, Rio E, Pacteau V. et al. OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer // BMC Cancer. - 2015. - Vol. 15. - P. 646.
Umbehr MH, Mntener M, Hany T. et al. The role of 11C-choline and 18 F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis // Eur Urol. - 2013. - Vol. 64. - P. 106-117.
Winter A, Henke R-P, Wawrochek F. Targeted salvage lymphadenectomy in patients with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume with lymph node recurrence over a long-term follow-up // BMC Urology. - 2015. - Vol. 15. - P. 10.
Winter A, Uphoff J, Henke RP, Wawroschek F. First results of [11C]choline PET/CT-guided secondary LN surgery in patients with PSA failure and single LN recurrence after radical retropubic prostatectomy // Urol Int. - 2010. - Vol. 84. - P. 418-423.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...